Have you ever gotten a note from your child's school with a long list of ingredients you can absolutely not pack in your child's lunch or bake into birthday snacks because of their classmates' allergies?
It can be frustrating to plan your child's meals around these restrictions, but think about the parents who have to worry about their child's life if they come face-to-face with a mere peanut.
Allergies are no joke, and severe allergic reactions can lead to a very scary and terrible death. Luckily, epinephrine is the medicine that will save lives if administered early enough.
EpiPen is a product that makes it so simple to administer this medication, that even a young child can learn how to administer it, saving their own life in the case of an attack.
However, over the past seven years since the drug was acquired by pharmaceutical company, Mylan, the price has hiked up to $600. While few people pay full-price out-of-pocket thanks to a good insurance plan, the price can still be incredibly steep for lower-income families who may not have the best insurance, or even none at all.
While Mylan announced that they will offer discounts to lower-income families, it's sometimes hard to determine who really needs the price cut. There is no filter to determine what struggles a family is going through financially at a certain time. A family right above the cutoff for the $300 discount may already be in debt from other medical bills.
The Wiesmans are worried for their daughter's life, because they simply do not know how they're going to be able to afford her lifesaving medicine.
What do you think about this price hike? Please SHARE with your family and friends on Facebook to see what they think!
